Delivery Order SPE2DB24D2102-SPE2DB24FJHPZ

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SENSOREADY 150 MG PENML. The award has a ceiling value of $20,527.68 and an ultimate completion date of March 6, 2025. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SENSOREADY 150 MG PENML. The contract has a ceiling value of $1,574.56 and a period of performance through February 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply COSENTYX SENSOREADY 150 MG PENML medication. The contract has a ceiling value of $45,720.68 and a period of performance through June 12, 2025. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, with a ceiling value of $9,447.36 and a completion date of March 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SENSOREADY 150 MG PENML, a specialty medication, with a ceiling value of $6,538.34 and a performance period through November 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,820.90 firm fixed-price contract is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The delivery order has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SENSOREADY 150 MG PENML. The delivery order is worth $27,227.39 and is a firm fixed-price contract with a completion date of December 12, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a medication, with a ceiling value of $23,743.23 and a period of performance ending on June 27, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,087.80, is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $53,010.37, and a performance period ending on May 2, 2025. The contract is not a set-aside and was competitively awarded. AmerisourceBergen Drug Corp...
  • SPE2DB24D2102
    Indefinite Delivery Contract
  • SPE2DB24D2102-SPE2DB24FJHPZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SENSOREADY 150 MG PENML medical products. The contract has a ceiling value of $18,622.80 and runs through July 2024. It is a firm fixed-price, delivery order contract type without a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 9:42 AM